BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16193086)

  • 1. Deletion of the inositide-specific phospholipase c beta1 gene is a rare event in myelodysplastic syndrome and thus of limited value to predict leukemic progression.
    Verburgh E; Verhoef G; Vandenberghe P; Hagemeijer A
    Leukemia; 2005 Nov; 19(11):2011-3. PubMed ID: 16193086
    [No Abstract]   [Full Text] [Related]  

  • 2. Inositide-specific phospholipase c beta1 gene deletion is a rare event in myelodysplastic syndromes.
    Herens C; Ketelslegers O; Tassin F; Hansen S; Bours V
    Leukemia; 2006 Mar; 20(3):521-2; author reply 522-3. PubMed ID: 16424863
    [No Abstract]   [Full Text] [Related]  

  • 3. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia.
    Lo Vasco VR; Calabrese G; Manzoli L; Palka G; Spadano A; Morizio E; Guanciali-Franchi P; Fantasia D; Cocco L
    Leukemia; 2004 Jun; 18(6):1122-6. PubMed ID: 15085153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to Herens et al.
    Lo Vasco VR; Follo MY; Cocco L
    Leukemia; 2006 Apr; 20(4):755. PubMed ID: 16437147
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
    Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
    J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study.
    Lim G; Oh SH; Choi JR; Lee HJ; Suh JT; Yoon HJ; Lee S; Lee WI; Park TS
    Leuk Res; 2010 Aug; 34(8):e208-9. PubMed ID: 20299095
    [No Abstract]   [Full Text] [Related]  

  • 9. del11(p11-13) with overexpression of Wilms' tumor gene during leukemic transformation of myelodysplastic syndrome.
    Suzuki S; Hashino S; Yoshida S; Chiba K; Izumiyama K; Kurosawa M; Musashi M; Asaka M
    Ann Hematol; 2002 Oct; 81(10):605-8. PubMed ID: 12424545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage check points prevent leukemic transformation in myelodysplastic syndrome.
    Horibe S; Takagi M; Unno J; Nagasawa M; Morio T; Arai A; Miura O; Ohta M; Kitagawa M; Mizutani S
    Leukemia; 2007 Oct; 21(10):2195-8. PubMed ID: 17495965
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
    Misawa S; Horiike S; Kaneko H; Kashima K
    Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factor.
    Damm F; Lange K; Heuser M; Oberacker T; Morgan M; Wagner K; Krauter J; Schlegelberger B; Ganser A; Göhring G
    J Clin Oncol; 2010 Aug; 28(22):e384-7; author reply e388-9. PubMed ID: 20516454
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.
    Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L
    Int J Mol Med; 2006 Aug; 18(2):267-71. PubMed ID: 16820933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.
    Douet-Guilbert N; Laï JL; Basinko A; Gueganic N; Andrieux J; Pollet B; Plantier I; Delattre C; Crépin O; Corm S; Le Bris MJ; Morel F; De Braekeleer M
    Br J Haematol; 2008 Dec; 143(5):716-20. PubMed ID: 19036015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the mouse phospholipase C-beta1 gene in a beta-lactoglobulin transgenic line affects viability, growth, and fertility in mice.
    Ballester M; Molist J; Lopez-Bejar M; Sánchez A; Santaló J; Folch JM; Ibáñez E
    Gene; 2004 Oct; 341():279-89. PubMed ID: 15474310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant isochromosome 17q and trisomy 14 in a patient with myelodysplastic syndrome in leukemic transformation.
    Park TS; Song J; Lee JH; Kim JS; Yang WI; Choi JR
    Ann Clin Lab Sci; 2009; 39(2):176-81. PubMed ID: 19429805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
    Jädersten M; Saft L; Smith A; Kulasekararaj A; Pomplun S; Göhring G; Hedlund A; Hast R; Schlegelberger B; Porwit A; Hellström-Lindberg E; Mufti GJ
    J Clin Oncol; 2011 May; 29(15):1971-9. PubMed ID: 21519010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.